PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 23, 2013PLoS ONE84 citationsOpen Access

Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability

YLYu‐Chen LiuCHChi-Sheng HungYWYen‐Wen Wu

Structured PICO

Does non-alcoholic fatty liver disease reduce heart rate variability in subjects without overt cardiovascular disease?

P
Population
497 subjects without an overt history of cardiovascular disease (mean age 46.2 years, 176 men and 321 women) enrolled during health checkups in Taiwan. Key exclusion criteria: past history of CVD, arrhythmia, pacemaker implant, use of drugs influencing the autonomic system, thyroid dysfunction, hemoglobin <10 g/dL, or eGFR <60 mL/min/1.73 m2.
I
Intervention
Presence of non-alcoholic fatty liver disease (NAFLD) diagnosed by ultrasonography
C
Comparator
Control group without NAFLD
O
Outcome
Heart rate variability (HRV) indices including time domain (SDNN, rMSSD), frequency domain (LF, HF), and symbolic dynamics analysis measured over 5 minutessurrogate

Non-alcoholic fatty liver disease is independently associated with decreased heart rate variability and increased sympathetic tone, suggesting early autonomic dysfunction in this population.

Limitations

  • Cross-sectional design; therefore, a causal relationship between NAFLD and changes in HRV parameters could not be demonstrated
  • NAFLD was defined by ultrasonic examination rather than by tissue biopsy

Abstract

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with cardiovascular atherosclerosis independent of classical risk factors. This study investigated the influence of NAFLD on autonomic changes, which is currently unknown. METHODS: Subjects without an overt history of cardiovascular disease were enrolled during health checkups. The subjects diagnosed for NAFLD using ultrasonography underwent 5-min heart rate variability (HRV) measurements that was analyzed using the following indices: (1) the time domain with the standard deviation of N-N (SDNN) intervals and root mean square of successive differences between adjacent N-N intervals (rMSSD); (2) the frequency domain with low frequency (LF) and high frequency (HF) components; and (3) symbolic dynamics analysis. Routine blood biochemistry data and serum leptin levels were analyzed. Homeostasis model assessment of insulin resistance (HOMA-IR) was measured. RESULTS: Of the 497 subjects (mean age, 46.2 years), 176 (35.4%) had NAFLD. The HRV indices (Ln SDNN, Ln rMSSD, Ln LF, and Ln HF) were significantly decreased in the NAFLD group (3.51 vs 3.62 ms, 3.06 vs 3.22 ms, 5.26 vs 5.49 ms(2), 4.49 vs 5.21 ms(2), respectively, all P<0.05). Ln SDNN was significantly lower in the NAFLD group after adjustment for age, sex, hypertension, dyslipidemia, metabolic syndrome, body mass index, smoking, estimated glomerular filtration rate, HOMA-IR, and leptin (P<0.05). In the symbolic dynamic analysis, 0 V percentage was significantly higher in the NAFLD group (33.8% vs 28.7%, P = 0.001) and significantly correlated with linear HRV indices (Ln SDNN, Ln rMSSD, and Ln HF). CONCLUSIONS: NAFLD is associated with decreased Ln SDNN and increased 0 V percentage. The former association was independent of conventional cardiovascular risk factors and serum biomarkers (insulin resistance and leptin). Further risk stratification of autonomic dysfunction with falls or cardiovascular diseases by these HRV parameters is required in patients with NAFLD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Liu et al. (2013) studied this question.

synapsesocial.com/papers/6a76150d1078cf7de2b2564chttps://doi.org/10.1371/journal.pone.0061803
Ask AI
Helpful
Bookmark
Share
View Full Paper